PRESS RELEASE published on 11/04/2025 at 07:00, 9 months 15 days ago Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate Valneva SE reports positive Phase 1 trial results for VLA1601, its second-generation Zika vaccine candidate, showing improved immune response. Safety and immunogenicity demonstrated in trial Phase 1 Trial Valneva SE Safety Immunogenicity Zika Vaccine
BRIEF published on 10/09/2025 at 16:04, 10 months 10 days ago Bpifrance Crosses Threshold in the Capital of Valneva SE Stock Market Valneva SE Threshold Crossing Bpifrance Deposit Fund
BRIEF published on 10/09/2025 at 16:04, 10 months 10 days ago Franchissement de Seuil par Bpifrance dans le Capital de Valneva SE Franchissement De Seuil Valneva SE Bpifrance Caisse Des Dépôts Marché Actions
PRESS RELEASE published on 10/09/2025 at 15:59, 10 months 10 days ago Franchissement de seuil Déclaration de franchissement de seuil de Bpifrance Participations SA pour VALNEVA SE et CDC, détenant respectivement 4,92% et 7,63% du capital de la société Déclaration Franchissement De Seuil Valneva SE CDC Bpifrance Participations SA
BRIEF published on 10/06/2025 at 07:35, 10 months 13 days ago Valneva Updates on Shares and Voting Rights Voting Rights Shares Euronext Valneva France
BRIEF published on 10/06/2025 at 07:35, 10 months 13 days ago Valneva fait le point sur ses actions et ses droits de vote Euronext Actions Droit De Vote Valneva France
PRESS RELEASE published on 10/06/2025 at 07:30, 10 months 13 days ago VALNEVA Déclaration d’actions et de droits de vote : 30 septembre 2025 VALNEVA fait une déclaration d'actions et de droits de vote, incluant des changements au porteur et en double droit de vote. Informations du 30 septembre 2025 Déclaration Droits De Vote Actions Valneva 30 Septembre 2025
PRESS RELEASE published on 10/06/2025 at 07:30, 10 months 13 days ago VALNEVA Declaration of shares and voting rights: September 30, 2025 Valneva declares transfer into bearer form of 653 shares with double voting rights and grants double voting rights on 100 ordinary shares, affecting total voting rights Voting Rights Valneva Shares Transfer Double Rights Bearer Form
BRIEF published on 09/03/2025 at 07:05, 11 months 16 days ago Progrès significatifs pour le vaccin contre la maladie de Lyme de Valneva Valneva Phase 2 Vaccin Lyme Immunogénicité Innocuité
BRIEF published on 09/03/2025 at 07:05, 11 months 16 days ago Valneva's Lyme Disease Vaccine Makes Significant Progress Valneva Safety Phase 2 Lyme Vaccine Immunogenicity
Published on 08/19/2026 at 22:00, 36 minutes ago Jaguar Health Reports Second Quarter 2026 Financials
Published on 08/19/2026 at 20:35, 2 hours 1 minute ago Revive Therapeutics Announces Proposed Shares for Debt Settlement
Published on 08/19/2026 at 18:50, 3 hours 46 minutes ago AmeriTrust Auto Advances End-to-End Lease Remarketing Strategy
Published on 08/19/2026 at 16:00, 6 hours 36 minutes ago Telefónica Chile and Amdocs Establish Strategic Multi-Year Agreement to Accelerate Modernization and Business Agility in Chile
Published on 08/19/2026 at 15:55, 6 hours 41 minutes ago Drill Permit Received for Storm Exploration's Gold Standard Project
Published on 08/19/2026 at 16:51, 5 hours 45 minutes ago AUTODOC and Apollo Funds successfully conclude transformative partnership
Published on 08/19/2026 at 16:15, 6 hours 21 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/18/2026 at 18:00, 1 day 4 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 4 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 11 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 11 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 2 hours ago Aéroports de Paris S.A - July 2026 traffic figures
